JP2019522044A5 - - Google Patents

Download PDF

Info

Publication number
JP2019522044A5
JP2019522044A5 JP2019515772A JP2019515772A JP2019522044A5 JP 2019522044 A5 JP2019522044 A5 JP 2019522044A5 JP 2019515772 A JP2019515772 A JP 2019515772A JP 2019515772 A JP2019515772 A JP 2019515772A JP 2019522044 A5 JP2019522044 A5 JP 2019522044A5
Authority
JP
Japan
Prior art keywords
subject
composition
fgf2
use according
fluid flow
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019515772A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019522044A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/035285 external-priority patent/WO2017210343A1/en
Publication of JP2019522044A publication Critical patent/JP2019522044A/ja
Publication of JP2019522044A5 publication Critical patent/JP2019522044A5/ja
Priority to JP2021207229A priority Critical patent/JP2022031368A/ja
Pending legal-status Critical Current

Links

JP2019515772A 2016-06-01 2017-05-31 中枢神経系におけるリンパ管を調節するための方法及び組成物 Pending JP2019522044A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021207229A JP2022031368A (ja) 2016-06-01 2021-12-21 中枢神経系におけるリンパ管を調節するための方法及び組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662344164P 2016-06-01 2016-06-01
US62/344,164 2016-06-01
PCT/US2017/035285 WO2017210343A1 (en) 2016-06-01 2017-05-31 Methods and compositions for modulating lymphatic vessels in the central nervous system

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021207229A Division JP2022031368A (ja) 2016-06-01 2021-12-21 中枢神経系におけるリンパ管を調節するための方法及び組成物

Publications (2)

Publication Number Publication Date
JP2019522044A JP2019522044A (ja) 2019-08-08
JP2019522044A5 true JP2019522044A5 (cg-RX-API-DMAC10.html) 2020-07-09

Family

ID=60477853

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019515772A Pending JP2019522044A (ja) 2016-06-01 2017-05-31 中枢神経系におけるリンパ管を調節するための方法及び組成物
JP2021207229A Pending JP2022031368A (ja) 2016-06-01 2021-12-21 中枢神経系におけるリンパ管を調節するための方法及び組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021207229A Pending JP2022031368A (ja) 2016-06-01 2021-12-21 中枢神経系におけるリンパ管を調節するための方法及び組成物

Country Status (6)

Country Link
US (1) US11944665B2 (cg-RX-API-DMAC10.html)
EP (1) EP3463575B1 (cg-RX-API-DMAC10.html)
JP (2) JP2019522044A (cg-RX-API-DMAC10.html)
AU (1) AU2017273629B2 (cg-RX-API-DMAC10.html)
CA (1) CA3025366A1 (cg-RX-API-DMAC10.html)
WO (1) WO2017210343A1 (cg-RX-API-DMAC10.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11944665B2 (en) 2016-06-01 2024-04-02 University Of Virginia Patent Foundation Methods and compositions for modulating lymphatic vessels in the central nervous system
JOP20190248A1 (ar) 2017-04-21 2019-10-20 Amgen Inc بروتينات ربط مولد ضد trem2 واستخداماته
WO2020018461A1 (en) * 2018-07-16 2020-01-23 The University Of Virginia Patent Foundation Compositions and methods of diagnosis and treatment for neurological diseases
KR20210100086A (ko) * 2018-10-04 2021-08-13 유니버시티 오브 로체스터 혈장 오스몰농도 조작에 의한 글림프 전달의 개선
KR20210093972A (ko) 2018-11-16 2021-07-28 예일 유니버시티 뇌 및 cns 종양 요법을 위한 수막 림프계 맥관구조의 조작
US20240050529A1 (en) * 2019-10-07 2024-02-15 University Of Virginia Patent Foundation Modulating lymphatic vessels in neurological disease
US20230067811A1 (en) 2020-01-24 2023-03-02 University Of Virginia Patent Foundation Modulating lymphatic vessels in neurological disease
CN114949182B (zh) * 2022-04-07 2025-07-01 上海大学 一种淋巴管生成诱导剂的用途
EP4608432A4 (en) * 2022-10-25 2026-08-12 Inst For Basic Science Ibs EXTRACTION METHODS TO ENABLE CEREBRAL-SPINAL FLUID DRAINAGE
WO2024173675A1 (en) * 2023-02-16 2024-08-22 University Of Rochester Improving glymphatic-lymphatic efflux

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4642303B2 (ja) 1999-09-21 2011-03-02 アンジェスMg株式会社 脳血管障害のための遺伝子治療
US20040214766A1 (en) * 2001-10-01 2004-10-28 Kari Alitalo VEGF-C or VEGF-D materials and methods for treatment of neuropathologies
CN1886149A (zh) 2003-09-23 2006-12-27 路德维格癌症研究院 Vegf-c或vegf-d物质及刺激神经干细胞的方法
US9415090B2 (en) * 2011-06-01 2016-08-16 Universität Heidelberg VEGF-D/VEGFR2/3-mediated regulation of dendrites
US8852936B2 (en) * 2012-09-21 2014-10-07 Laurantis Pharma Oy Autologous lymph node transfer in combination with VEGF-C or VEGF-D growth factor therapy to treat lymphedema and to improve reconstructive surgery
WO2017190074A1 (en) 2016-04-28 2017-11-02 The University Of Chicago Lymphangiogenesis for therapeutic immunomodulation
US11944665B2 (en) 2016-06-01 2024-04-02 University Of Virginia Patent Foundation Methods and compositions for modulating lymphatic vessels in the central nervous system
KR20210093972A (ko) 2018-11-16 2021-07-28 예일 유니버시티 뇌 및 cns 종양 요법을 위한 수막 림프계 맥관구조의 조작

Similar Documents

Publication Publication Date Title
Hall et al. In vivo tau PET imaging in dementia: pathophysiology, radiotracer quantification, and a systematic review of clinical findings
Andica et al. MR biomarkers of degenerative brain disorders derived from diffusion imaging
Pieperhoff et al. Regional changes of brain structure during progression of idiopathic Parkinson's disease–a longitudinal study using deformation based morphometry
Villemagne Amyloid imaging: past, present and future perspectives
Lazarov et al. Neurogenesis and Alzheimer's disease: at the crossroads
Wei et al. White matter abnormalities in patients with Parkinson's disease: a meta-analysis of diffusion tensor imaging using tract-based spatial statistics
Oeckl et al. Cerebrospinal fluid proteomics and protein biomarkers in frontotemporal lobar degeneration: current status and future perspectives
Bărbulescu et al. Neuroinflammation in systemic lupus erythematosus-a review
Doorn et al. Hippocampal proliferation is increased in presymptomatic Parkinson’s disease and due to microglia
US11944665B2 (en) Methods and compositions for modulating lymphatic vessels in the central nervous system
Wang et al. Association of longitudinal cognitive decline with diffusion MRI in gray matter, amyloid, and tau deposition
Gambino et al. Aging and neuroinflammatory disorders: new biomarkers and therapeutic targets
Madeira et al. Glia-mediated retinal neuroinflammation as a biomarker in Alzheimer's disease
Avants et al. Amyloid beta–Positive subjects exhibit longitudinal network-specific reductions in spontaneous brain activity
Del Bigio et al. Neuropathology of human hydrocephalus
Macijauskienė et al. Dementia with Lewy bodies: the principles of diagnostics, treatment, and management
Oggioni et al. The glymphatic system: a potential key player in bacterial meningitis
Breza et al. Diffuse glioma manifesting as normal pressure hydrocephalus: A potential pitfall in diagnosis-a case report
Hafez et al. A new era in neuropharmacology: assessing the efficacy and safety of novel anti-amyloid and non-amyloid drug targets for Alzheimer's disease
Bašić et al. Apolipoprotein E and matrix remodeling–a link to neurodegeneration in Alzheimer’s disease
Olsson Evaluation of amyloid precursor protein and beta-amyloid as biomarkers for Alzheimer's disease.
Apostolova Structural neuroimaging in degenerative dementias
PINTO et al. Normal pressure hydrocephalus: Neuroimaging as a tool for differential diagnosis and outcome predictor
Chen et al. Neuroimaging-Based Glymphatic Function Predicts Conversion from Prodromal to Manifest Parkinson's Disease
ZHANG et al. Reversible cerebral vasoconstriction syndrome characterized by postpartum headache: a case report